J. Safra Sarasin Holding Ag Biomarin Pharmaceutical Inc Transaction History
J. Safra Sarasin Holding Ag
- $5.47 Trillion
- Q2 2024
A detailed history of J. Safra Sarasin Holding Ag transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 26,690 shares of BMRN stock, worth $1.79 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
26,690Holding current value
$1.79 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
620Shares Held
183MCall Options Held
1.41MPut Options Held
1.31M-
Black Rock Inc. New York, NY22.7MShares$1.53 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.27 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.27 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$934 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$650 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...